Coloplast A/S B Forecast, price target & analysts
Coloplast A/S B Target price 2026 - Analyst rating & recommendation
Coloplast A/S B Classifications & Recommendation
Coloplast A/S B Price Target
| Target Price | kr469.20 |
| Price | kr420.10 |
| Potential |
11.69%
register free of charge
|
| Number of Estimates | 25 |
|
25 Analysts have issued a price target Coloplast A/S B 2027 .
The average Coloplast A/S B target price is kr469.20.
This is
11.69%
register free of charge
kr656.25
56.21%
register free of charge
kr393.90
6.24%
register free of charge
|
|
| A rating was issued by 28 analysts: 8 Analysts recommend Coloplast A/S B to buy, 16 to hold and 4 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Coloplast A/S B stock has an average upside potential 2027 of
11.69%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2033
| Sep '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion kr | 27.87 | 29.14 |
| 3.12% | 4.53% | |
| EBITDA Margin | 30.42% | 31.91% |
| 1.89% | 4.90% | |
| Net Margin | 13.04% | 19.71% |
| 30.21% | 51.10% |
25 Analysts have issued a sales forecast Coloplast A/S B 2026 . The average Coloplast A/S B sales estimate is
This results in the following potential growth metrics:
24 Analysts have issued an Coloplast A/S B EBITDA forecast 2026. The average Coloplast A/S B EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
25 Coloplast A/S B Analysts have issued a net profit forecast 2026. The average Coloplast A/S B net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033
| Sep '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share kr | 16.13 | 25.48 |
| 28.18% | 57.97% | |
| P/E | 16.46 | |
| EV/Sales | 4.03 |
25 Analysts have issued a Coloplast A/S B forecast for earnings per share. The average Coloplast A/S B EPS is
This results in the following potential growth metrics and future valuations:
Coloplast A/S B...
Current Coloplast A/S B Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| JYSKE BANK |
Locked
➜
Locked
|
Locked | Jul 13 2026 |
| BERENBERG |
Locked
➜
Locked
|
Locked | Jul 13 2026 |
| ROTHSCHILD & CO REDBURN |
Locked
➜
Locked
|
Locked | Jul 08 2026 |
| JEFFERIES |
Locked
➜
Locked
|
Locked | Jul 01 2026 |
| EQUITA SIM |
Locked
➜
Locked
|
Locked | Jun 11 2026 |
| BAADER EUROPE / ALPHAVALUE |
Locked
➜
Locked
|
Locked | Jun 07 2026 |
| HANDELSBANKEN CAPITAL MARKETS |
Locked
➜
Locked
|
Locked | May 12 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
JYSKE BANK:
Locked
➜
Locked
|
Jul 13 2026 |
|
Locked
BERENBERG:
Locked
➜
Locked
|
Jul 13 2026 |
|
Locked
ROTHSCHILD & CO REDBURN:
Locked
➜
Locked
|
Jul 08 2026 |
|
Locked
JEFFERIES:
Locked
➜
Locked
|
Jul 01 2026 |
|
Locked
EQUITA SIM:
Locked
➜
Locked
|
Jun 11 2026 |
|
Locked
BAADER EUROPE / ALPHAVALUE:
Locked
➜
Locked
|
Jun 07 2026 |
|
Locked
HANDELSBANKEN CAPITAL MARKETS:
Locked
➜
Locked
|
May 12 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
